Pharmacokinetics And Pharmacodynamics Of Curcumin.
Ricky A. Sharma, William P. Steward, Andreas J. Gescher
Published 2007 · Medicine
Download PDFAnalyze on Scholarcy
Curcuma spp. contain turmerin, essential oils, and curcuminoids, including curcumin. Curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] is regarded as the most biologically active constituent of the spice turmeric and it comprises 2-8% of most turmeric preparations. Preclinical data from animal models and phase I clinical studies performed with human volunteers and patients with cancer have demonstrated low systemic bioavailability following oral dosing. Efficient first-pass metabolism and some degree of intestinal metabolism, particularly glucuronidation and sulfation of curcumin, might explain its poor systemic availability when administered via the oral route. A daily oral dose of 3.6 g of curcumin is compatible with detectable levels of the parent compound in colorectal tissue from patients with cancer. The levels demonstrated might be sufficient to exert pharmacological activity. There appears to be negligible distribution of the parent drug to hepatic tissue or other tissues beyond the gastrointestinal tract. Curcumin possesses wide-ranging anti-inflammatory and anticancer properties. Many of these biological activities can be attributed to its potent antioxidant capacity at neutral and acidic pH, its inhibition of cell signaling pathways at multiple levels, its diverse effects on cellular enzymes, and its effects on cell adhesion and angiogenesis. In particular, curcumin's ability to alter gene transcription and induce apoptosis in preclinical models advocates its potential utility in cancer chemoprevention and chemotherapy. With regard to considerable public and scientific interest in the use of phytochemicals derived from dietary components to combat or prevent human diseases, curcumin is currently a leading agent.
This paper references
The seventh DeWitt S
A. H. Conney (2003)
An ultrasound study
A. Raysid (1999)
Nitric oxide inhibits DNA ligase activity : Potential mechanisms for NOmediated DNA damage
D. A. Wink M. Graziewicz (1996)
Plants Consumed by Man.
Robert Ornduff (1975)
Biotransformation of curcumin through reduction and glucuronidation in mice.
M H Pan (1999)
Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels.
Ricky A. Sharma (2001)
Induction of rat hepatic and intestinal glutathione s-transferases and glutathione by dietary naturally-occurring anticarcinogens.
Wim A. Nijhoff (1993)
Studies with [3H] curcumin
V. Ravindranath (1981)
Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin.
Shivendra V. Singh (1998)
Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage.
M Graziewicz (1996)
An essential regulator of NOmediated apoptosis
A. Von Knethen (1997)
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.
G. Shoba (1998)
In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties.
Marion M Chan (1998)
Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study
Peter R. Holt (2005)
Clinical development plan: curcumin.
Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells.
Moon-Sook Woo (2005)
Induction of glutathione S-transferase activity by curcumin in mice.
M. Susan (1992)
Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells 1
Alok Chandra Bharti (2003)
Metabolism of curcumin--studies with [3H]curcumin.
Vijayalakshmi Ravindranath (1981)
Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells.
Henry P. Ciolino (1998)
Nitric oxide induces oxidative damage in addition to deaminiation in macrophage DNA
T. deRojas-Walker (1995)
Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with post-operative inflammation
R. R. Satoskar (1986)
Immunosuppressants: cellular and molecular mechanisms of action.
Manikkam Suthanthiran (1996)
Efficacy of curcumin in the management of chronic anterior uveitis.
Birendra K. Lal (1999)
Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex
Simon M Plummer (1999)
Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes.
Albena T. Dinkova-Kostova (1999)
Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer.
Stefan Ambs (1999)
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines.
M C Jiang (1996)
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
Ricky A. Sharma (2001)
NF- B and AP-1 activation by nitric oxide attenuated apoptotic death in RAW 264.7 macrophages
A. Von Knethen (1999)
A study on the fate of curcumin in the rat.
Bo A. Wahlström (1978)
Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-κB and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization*
Smitha V. Bava (2005)
Curcumin Content of Turmeric and Curry Powders
Reema F Tayyem (2006)
Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents.
Simon M Plummer (2001)
The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat.
Gerald M. Holder (1978)
Curcurmin activates the haem oxygenase1 gene via regulation of Nrf 2 and the antioxidantresponsive element
M. Hoque (2003)
Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
Sarah Perkins (2002)
Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin.
Ning Li (2002)
Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice
Bharat Bhushan Aggarwal (2005)
Pharmacology of Curcuma longa.
Hermann P. T. Ammon (1991)
The pilot study.
C Baird (2000)
Inhibition of tumor necrosis factor by curcumin, a phytochemical.
Marion M Chan (1995)
Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.
Allan H. Conney (2003)
Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis.
Andreas von Knethen (1997)
Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects
Marie E Egan (2004)
Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Hiba Samaha (1997)
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
Ai-Ling Cheng (2001)
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
Giuseppe Garcea (2004)
Phase I Clinical Trial of Oral Curcumin
Ricky A. Sharma (2004)
The effect of curcumin and placebo on human gall-bladder function: an ultrasound study.
Abdul Rasyid (1999)
Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis.
Katsumi Imaida (2001)
Turmeric and Curcumin as Topical Agents in Cancer Therapy
Ramadasan Kuttan (1987)
Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action
Bina Joe (2004)
Preliminary study on antirheumatic activity of curcumin (diferuloyl methane).
Sharad D. Deodhar (1980)
Absorption and tissue distribution of curcumin in rats.
Vijayalakshmi Ravindranath (1980)
Modification by dietary curcumin and implications for clinical trials
R. G. Tunstall (2006)
Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.
Christopher R. Ireson (2002)
Role of nitric oxide in carcinogenesis and tumour progression.
P. K. Lala (2001)
Loss of Apc+ in intestinal adenomas from Min mice.
Cindy L. Luongo (1994)
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells.
Mu-Yi Kuo (1996)
Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin).
Suresh R Volate (2005)
Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages.
Yoshiyuki Abe (1999)
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
Ken Sugimoto (2002)
Role of curcumin in idiopathic inflammatory orbital pseudotumours.
Birendra K. Lal (2000)
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
Christopher R. Ireson (2001)
Action of curcumin on the cytochrome P450-system catalyzing the activation of aflatoxin B1.
Pervez F Firozi (1996)
Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells.
Wen-Hsiung Chan (2004)
Reversal of aflatoxin induced liver damage by turmeric and curcumin.
K B Soni (1992)
Antimutagenic potential of curcumin on chromosomal aberrations in Wistar rats.
Yogeshwer Shukla (2002)
Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition.
Annelyse Duvoix (2004)
Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells.
Brij Mohan Gupta (1999)
Involvement of Nrf2, p38, B-Raf, and Nuclear Factor-κB, but Not Phosphatidylinositol 3-Kinase, in Induction of Hemeoxygenase-1 by Dietary Polyphenols
Catherine K Andreadi (2006)
Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal.
D. Eigner (1999)
The glutathione S-transferases supergene family
J. D. Hayes (1995)
Relationship with drug levels
R. A. Sharma (2001)
Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells.
Gavin P. Collett (2004)
Curcumin Suppresses Interleukin 1β-Mediated Microsomal Prostaglandin E Synthase 1 by Altering Early Growth Response Gene 1 and Other Signaling Pathways
Yuseok Moon (2005)
Anticancer potential of curcumin: preclinical and clinical studies.
Bharat Bhushan Aggarwal (2003)
Dose escalation of curcumin in healthy adults
M. T. Ruffin (2003)
The effect of curcumin on glutathione linked detoxification enzymes in rat liver
J. T. Piper (1998)
Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver.
John T. Piper (1998)
Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages.
I Brouet (1995)
Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials.
Richard George Tunstall (2006)
Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin.
Chunhong Yan (2005)
Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
Giuseppe S. Garcea (2005)
In vitro studies on the intestinal absorption of curcumin in rats.
Vijayalakshmi Ravindranath (1981)
Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells.
Frederick Zhang (1999)
Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.
Chinthalapally V Rao (1995)
Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
Toshihiko Kawamori (1999)
This paper is referenced by
Curcumin Monoglucoside Shows Improved Bioavailability and Mitigates Rotenone Induced Neurotoxicity in Cell and Drosophila Models of Parkinson’s Disease
M. D. Pandareesh (2016)
Skeletal Muscle as a Therapeutic Target for Natural Products to Reverse Metabolic Syndrome
Sithandiwe E Mazibuko-Mbeje (2018)
Curcumin serves as a human kv1.3 blocker to inhibit effector memory T lymphocyte activities.
Yi-tian Lian (2013)
Handbook of 200 Medicinal Plants: A Comprehensive Review of Their Traditional Medical Uses and Scientific Justifications
Shahid Akbar (2020)
Lung-targeted delivery system of curcumin loaded gelatin microspheres
Fengliang Cao (2011)
Curcumin for inflammatory bowel disease: a review of human studies.
Rebecca A Taylor (2011)
Progress in Nanotechnology Based Approaches to Enhance the Potential of Chemopreventive Agents
Irfana Muqbil (2011)
Curcumin: a novel therapeutic for burn pain and wound healing
Bopaiah P Cheppudira (2013)
Synthesis, Antimalarial Activity, and Docking Studies of Monocarbonyl Analogues of Curcumin
A. St. Hajrah Yusuf (2018)
Influence of curcumin on pioglitazone metabolism and pk/pd: Diabetes Mellitus
Prasad Neerati (2013)
Targeting Curcusomes to Inflammatory Dendritic Cells Inhibits NF-κB and Improves Insulin Resistance in Obese Mice
Suman Kumar Yekollu (2011)
Oxidative/nitrative stress in the pathogenesis of systemic sclerosis: are antioxidants beneficial?
Paul R. J. Ames (2018)
EVALUATION OF STABILITY, CELLULAR UPTAKE AND ANTI-TUMOUR ACTIVITIES OF AN OPTIMIZED CURCUMIN SOLID LIPID NANOPARTICLES FORMULATION.
Hamdy M. Dawaba (2015)
Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study
Fabio Mazzolani (2013)
New Concepts of Chronic Pain and the Potential Role of Complementary Therapies.
K. Wojcikowski (2018)
Curcumin and liver disease.
Laura Vera-Ramirez (2013)
Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model.
Hossam M. M. Arafa (2009)
ment with curcumin causes ER stress-related apoptosis of cancer cell lines, including human leukemia HL-60, murine melanoma B16-F10 and non-human lung cancer A549 cells
Xie Zhang (2012)
Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.
Vesna Milacic (2008)
Plant in vitro culture for the production of antioxidants--a review.
Adam Matkowski (2008)
Crystal structure of ortho-(2e,5e) - 2,5-bis(2-methoxy-benzylidene)cyclopentanone,C21H20O3
Chengguang Zhao (2009)
Particle size modification of curcumin and its effect on plasma and tissue distribution
Melva Louisa (2019)
A Highly Luminescent Tetrahydrocurcumin IrIII Complex with Remarkable Photoactivated Anticancer Activity.
Alessia Colombo (2019)
Curcuma longa L. (Zingiberaceae)
Shahid Akbar (2020)
Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation.
Siddhartha S. Ghosh (2009)
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer
Richard Greil (2018)
Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study.
Yoichi Sunagawa (2015)
Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer’s and neurodegenerative diseases
Neelima Ayyalasomayajula (2018)
Turmeric active substance, curcumin, enhanced apomorphine-induced yawning in rats
Esmaeal Tamaddonfard (2013)
Acupuncture Combined with Curcumin Attenuates Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats
Feng Zhang (2012)
Comparative oral bioavailability advantage from curcumin formulations
Bhushan Munjal (2011)
Nanotechnology applications for the therapy of liver fibrosis.
Lydia Giannitrapani (2014)See more